What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to health
- Committee discharged and committed to health
- Referred to social services
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Prohibits medicaid's use of any prior approval or preferred drug list requirement for AIDS, HIV, infection, or hepatitis C
In Assembly Committee · Social Services · Sponsor Susan John
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
Title of bill
An act to amend the social services law, in relation to establishing a prohibition on prior approval or preferred drug list requirements for certain drugs used to treat AIDS, HIV infection or hepatitis C
Purpose
To prohibit prior approval or preferred drug list requirements for certain drugs used to treat AIDS, HIV infection, or hepatitis C.
Summary of provisions
Section 1 prohibits prior authorization or preferred drug list program requirements for prescription drugs deemed to be medically necessary for the treatment and prevention of AIDS, HIV infection and hepatitis C. Section 2 is the severability clause.
Justification
Hepatitis C is rapidly emerging as one of New York's most significant public health issues. Currently, there are approximately 342,000 New Yorkers living with acute or chronic Hepatitis C and approximately 40,000 New Yorkers living with co-infection of HIV and Hepatitis C. Of this 40,000 it is estimated that 43% are African American and 29% are Hispanic. For these New Yorkers, hope lies in early treatment. Early diagnosis, early treatment and early access to Hepatitis C drugs are essential to the long-term health of the patient. The use of Hepatitis C drugs in the early stages of the virus, not only reduces the likelihood that a patient will spread the virus, but also reduces the likelihood that a patient will require an expensive liver transplant. The establishment of a prohibition on prior approval or preferred drug list requirements for certain AIDS, HIV infection and Hepatitis C drugs will help prevent the possibility of a future barrier to drug treatment and will help put the patient on a faster track to wellness.
Legislative history
01/09/08 REFERRED TO SOCIAL SERVICES, CHILDREN AND FAMILIES
Fiscal implications
To be determined.
Effective date
This act shall take effect on the first of January next succeeding the date on which it shall have become a law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.